Cormorant Asset Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Cormorant Asset Management’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-300,000	Closed	-$6.73M	–	94
2021 Q3	$6.73M	Sell	300,000 -242,499	-45%	-$5.32M	0.27%	63
2021 Q2	$12.4M	Sell	542,499 -457,501	-46%	-$9.63M	0.42%	57
2021 Q1	$20.6M	Sell	1,000,000 -700,000	-41%	-$15.9M	0.46%	50
2020 Q4	$47M	Sell	1,700,000 -434,966	-20%	-$8.47M	1.12%	31
2020 Q3	$30M	Sell	2,134,966 -365,034	-15%	-$6.79M	1.15%	31
2020 Q2	$51.5M	Sell	2,500,000 -100,000	-4%	-$1.36M	1.97%	19
2020 Q1	$19.6M	Buy	2,600,000 +600,000	+30%	+$6.73M	0.91%	35
2019 Q4	$31M	Buy	+2,000,000	New	+$20.2M	1.24%	28
2019 Q2	–	Sell	-650,000	Closed	-$15.5M	–	78
2019 Q1	$15.5M	Buy	+650,000	New	+$13.3M	1.05%	32
2017 Q3	–	Sell	-100,000	Closed	-$1.17M	–	68
2017 Q2	$1.17M	Hold	100,000	–	–	0.19%	60
2017 Q1	$1.17M	Hold	100,000	–	–	0.17%	67
2016 Q4	$1.24M	Buy	+100,000	New	+$1.16M	0.17%	67

Other funds holding MYOV

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Cormorant Asset Management's MYOV Position: Q4 2021 in Review

Cormorant Asset Management sold out of Myovant Sciences Ltd. (MYOV) in Q4 2021, closing a stake of 300,000 shares — an estimated $6.73M sold.

Cormorant Asset Management first reported a position in MYOV in Q4 2016 and held it in 12 quarters. The position peaked at $51.5M in Q2 2020. 110 funds tracked by Wall St. Rank hold MYOV as of Q4 2021.

Cormorant Asset Management reported no remaining Myovant Sciences Ltd. position as of Q4 2021 after selling out during the quarter.
Cormorant Asset Management sold 300,000 Myovant Sciences Ltd. shares in Q4 2021, an estimated $6.73M.
Cormorant Asset Management first reported a position in Myovant Sciences Ltd. in Q4 2016 and held it in 12 quarters.
Cormorant Asset Management's Myovant Sciences Ltd. position peaked at $51.5M in Q2 2020.
110 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2021.

Based on Cormorant Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.